Feb 18, 2020
Theravance Biopharma Announces Presentations at Upcoming Investor Conferences
Jan 31, 2020
Lilly's REYVOW(TM) (lasmiditan) C-V, the First and Only Medicine in a New Class of Acute Treatment for Migraine (ditan), Now Available for Prescription
Jan 21, 2020
LUNGevity and the ALK Positive Group Partner to Fund $1 Million in Lung Cancer Research Awards
Jan 14, 2020
ANI Announces Launch of Paliperidone Extended-Release Tablets
Jan 14, 2020
Health Canada Approves Astellas' XOSPATA® (gilteritinib) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation
Jan 13, 2020
Spectra Medical Devices - Huons Co., Ltd. Announce FDA Approval to Market Bupivacaine HCL in Dextrose USP, 0.75% / 8.25% 2 mL Glass Ampules
Jan 13, 2020
AcelRx Announces Year-End 2019 Metrics and Provides Corporate Updates
Jan 07, 2020
Theravance Biopharma Announces Presentation at the 38th Annual J.P. Morgan Healthcare Conference
Dec 17, 2019
Medicure Announces the Completion of Shortened AGGRASTAT® Versus Integrilin® in Percutaneous Coronary Intervention (SAVI-PCI) Study
Dec 12, 2019
Medicure Announces Completion of Enrollment for FABOLUS-FASTER, Phase 4 Clinical Trial of Aggrastat (Tirofiban Hydrochloride) Injection VS Kengreal (Cangrelor) in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Dec 11, 2019
Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value
Dec 06, 2019
Enteris BioPharma's Licensing Partner, Cara Therapeutics, Announces Top Line Data from Phase 2 Trial of Peptelligence®-Engineered Oral KORSUVA(TM) for the Treatment of Pruritus in Patients with Advanced Chronic Kidney Disease (CKD)
Dec 05, 2019
Medicure Files Patent Infringement Action
Dec 03, 2019
Theravance Biopharma Announces Dosing of First Patient in Phase 2 Allergen Challenge Study of TD-8236, an Investigational, Lung-Selective, Inhaled Pan-Janus Kinase (JAK) Inhibitor for Inflammatory Lung Diseases
Nov 06, 2019
Theravance Biopharma to Present at the 2019 Credit Suisse Healthcare Conference
Oct 30, 2019
European Commission Approves Astellas' XOSPATA(TM) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Mutations Detected using Invivoscribe's LeukoStrat® CDx FLT3 Mutation Assay
Oct 29, 2019
Theravance Biopharma to Report Third Quarter 2019 Financial Results on November 5
Oct 21, 2019
Theravance Biopharma and Mylan to Present New Data on YUPELRI® (revefenacin) at the 2019 CHEST Annual Meeting
Oct 18, 2019
America's endless battle against lethal drug fentanyl
Oct 11, 2019
Dana Point Rehab Campus CEO Michael Castanon Discusses the Fentanyl Crisis on CBS-LA